There is no question that making the material for billions of protective masks is related to fighting the pandemic, and that is what Lydall Inc. plans to do at its Rochester plant with the CARES Act funding it received.

Infection preventionists and other healthcare professionals still feel the scars of not having enough personal protective equipment (PPE) on hand when coronavirus disease 2019 (COVID-19) first hit back in the beginning of the year.

A consistent demand for personal protective equipment continues to bolster sales figures at Manchester-based Lydall Inc.

Congressman Chris Pappas met with leaders from New Hampshire-based manufacturing companies at Lydall Performance Materials in Rochester Friday.

Despite hopes that the number of coronavirus cases would be on the decline by now, quite the opposite is true. After dipping down to the lowest point of 30,000 to 35,000 new daily cases, the United States is back up to about 50,000 new cases a day.

In 2013, just months before she became CEO of General Motors, Mary Barra gave a commencement address to graduates at her alma mater, Kettering University. She emphasized the merits of hard work and tenacity.

While a number of industry CEOs have argued for government support for production of Personal Protective Equipment (PPEs) as well as their raw materials, Sara Greenstein of Lydall Inc. has been a consistent advocate this year for both governments and companies to take steps to develop a vibrant ongoing PPE supply chain in the United States and Europe.

“From the moment COVID hit in China we were working hard to produce every ounce we were capable of,” Chief Executive Officer Sara Greenstein said.